Progyny, Inc. (NASDAQ:PGNY) Shares Acquired by Kornitzer Capital Management Inc. KS

Kornitzer Capital Management Inc. KS raised its stake in shares of Progyny, Inc. (NASDAQ:PGNY) by 15.7% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 976,501 shares of the company’s stock after purchasing an additional 132,672 shares during the period. Kornitzer Capital Management Inc. KS owned 1.08% of Progyny worth $16,366,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of PGNY. Allspring Global Investments Holdings LLC grew its position in Progyny by 9.5% during the first quarter. Allspring Global Investments Holdings LLC now owns 6,260 shares of the company’s stock valued at $239,000 after acquiring an additional 543 shares during the period. Norden Group LLC acquired a new position in shares of Progyny during the first quarter worth $566,000. Janney Montgomery Scott LLC acquired a new stake in shares of Progyny during the first quarter valued at about $213,000. Nordea Investment Management AB increased its position in shares of Progyny by 122.2% during the first quarter. Nordea Investment Management AB now owns 126,446 shares of the company’s stock worth $4,891,000 after acquiring an additional 69,552 shares during the last quarter. Finally, Texas Permanent School Fund Corp lifted its stake in shares of Progyny by 1.4% in the first quarter. Texas Permanent School Fund Corp now owns 72,971 shares of the company’s stock worth $2,784,000 after acquiring an additional 974 shares in the last quarter. Hedge funds and other institutional investors own 94.93% of the company’s stock.

Analysts Set New Price Targets

PGNY has been the topic of several analyst reports. Cantor Fitzgerald restated an “overweight” rating and set a $25.00 price objective on shares of Progyny in a report on Tuesday, October 1st. Truist Financial reduced their price target on shares of Progyny from $33.00 to $26.00 and set a “buy” rating on the stock in a research report on Thursday, September 19th. Leerink Partnrs lowered Progyny from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 7th. Leerink Partners reduced their target price on Progyny from $25.00 to $21.00 and set a “market perform” rating on the stock in a report on Thursday, September 19th. Finally, Jefferies Financial Group dropped their target price on shares of Progyny from $31.00 to $24.00 and set a “buy” rating on the stock in a report on Thursday, September 19th. Seven equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $27.73.

Progyny Price Performance

PGNY stock traded down $0.02 on Thursday, reaching $16.36. The company’s stock had a trading volume of 105,520 shares, compared to its average volume of 1,365,205. The firm has a fifty day moving average of $18.39 and a two-hundred day moving average of $24.13. The company has a market capitalization of $1.48 billion, a P/E ratio of 26.00, a price-to-earnings-growth ratio of 1.43 and a beta of 1.44. Progyny, Inc. has a 52 week low of $13.93 and a 52 week high of $42.08.

Progyny (NASDAQ:PGNY) last issued its quarterly earnings data on Tuesday, August 6th. The company reported $0.17 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.17. The business had revenue of $304.09 million for the quarter, compared to analysts’ expectations of $305.32 million. Progyny had a net margin of 5.54% and a return on equity of 11.97%. The company’s revenue was up 8.8% on a year-over-year basis. During the same period in the previous year, the business earned $0.15 earnings per share. As a group, equities analysts expect that Progyny, Inc. will post 0.64 EPS for the current fiscal year.

About Progyny

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.